Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
CNY 8.04
(1.9%)
CNY 8.04
(1.9%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 331.11 Million CNY | -14.31% |
| 2022 | 430.24 Million CNY | -27.78% |
| 2021 | 595.77 Million CNY | 41.41% |
| 2020 | 421.32 Million CNY | -6.27% |
| 2019 | 449.49 Million CNY | 16.08% |
| 2018 | 387.22 Million CNY | -0.69% |
| 2017 | 389.89 Million CNY | -2.82% |
| 2016 | 401.19 Million CNY | 72.04% |
| 2015 | 233.2 Million CNY | 39.21% |
| 2014 | 167.52 Million CNY | 9.38% |
| 2013 | 153.16 Million CNY | 14.93% |
| 2012 | 133.26 Million CNY | 29.93% |
| 2011 | 102.56 Million CNY | 33.28% |
| 2010 | 76.95 Million CNY | 18.97% |
| 2009 | 64.68 Million CNY | 25.05% |
| 2008 | 51.72 Million CNY | 55.31% |
| 2007 | 33.3 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 86.3 Million CNY | -19.39% |
| 2024 Q3 | 90.25 Million CNY | 18.48% |
| 2024 Q2 | 74.08 Million CNY | -14.15% |
| 2023 Q4 | 107.05 Million CNY | 4.42% |
| 2023 FY | 368.67 Million CNY | -14.31% |
| 2023 Q1 | 82.58 Million CNY | -31.47% |
| 2023 Q2 | 76.51 Million CNY | -7.35% |
| 2023 Q3 | 102.52 Million CNY | 34.0% |
| 2022 Q3 | 76.24 Million CNY | -27.53% |
| 2022 Q1 | 128.29 Million CNY | -32.87% |
| 2022 Q2 | 105.2 Million CNY | -18.0% |
| 2022 FY | 430.24 Million CNY | -27.78% |
| 2022 Q4 | 120.49 Million CNY | 58.05% |
| 2021 Q1 | 119.29 Million CNY | 22.97% |
| 2021 Q2 | 146.59 Million CNY | 22.88% |
| 2021 Q3 | 138.78 Million CNY | -5.32% |
| 2021 Q4 | 191.1 Million CNY | 37.7% |
| 2021 FY | 595.77 Million CNY | 41.41% |
| 2020 Q1 | 101.76 Million CNY | -28.18% |
| 2020 Q3 | 128.2 Million CNY | 35.9% |
| 2020 Q4 | 97.01 Million CNY | -24.33% |
| 2020 FY | 421.32 Million CNY | -6.27% |
| 2020 Q2 | 94.34 Million CNY | -7.29% |
| 2019 Q3 | 114.16 Million CNY | 34.81% |
| 2019 FY | 449.49 Million CNY | 16.08% |
| 2019 Q1 | 108.95 Million CNY | 3.57% |
| 2019 Q2 | 84.68 Million CNY | -22.28% |
| 2019 Q4 | 141.67 Million CNY | 24.1% |
| 2018 FY | 387.22 Million CNY | -0.69% |
| 2018 Q4 | 105.2 Million CNY | 2.08% |
| 2018 Q3 | 103.05 Million CNY | 15.69% |
| 2018 Q2 | 89.08 Million CNY | -0.98% |
| 2018 Q1 | 89.96 Million CNY | -28.89% |
| 2017 Q3 | 86.11 Million CNY | -8.31% |
| 2017 FY | 389.89 Million CNY | -2.82% |
| 2017 Q4 | 126.52 Million CNY | 46.92% |
| 2017 Q1 | 83.34 Million CNY | -43.08% |
| 2017 Q2 | 93.91 Million CNY | 12.69% |
| 2016 Q4 | 146.4 Million CNY | 57.66% |
| 2016 Q3 | 92.86 Million CNY | 1.26% |
| 2016 Q2 | 91.7 Million CNY | 30.61% |
| 2016 FY | 401.19 Million CNY | 72.04% |
| 2016 Q1 | 70.21 Million CNY | -26.06% |
| 2015 FY | 233.2 Million CNY | 39.21% |
| 2015 Q4 | 94.96 Million CNY | 97.97% |
| 2015 Q3 | 47.96 Million CNY | 7.27% |
| 2015 Q2 | 44.71 Million CNY | -1.85% |
| 2015 Q1 | 45.56 Million CNY | -27.07% |
| 2014 FY | 167.52 Million CNY | 9.38% |
| 2014 Q4 | 62.46 Million CNY | 74.76% |
| 2014 Q3 | 35.74 Million CNY | 0.21% |
| 2014 Q2 | 35.66 Million CNY | 6.04% |
| 2014 Q1 | 33.63 Million CNY | -37.76% |
| 2013 Q1 | 33.64 Million CNY | 143.34% |
| 2013 FY | 153.16 Million CNY | 14.93% |
| 2013 Q3 | 33.79 Million CNY | 6.69% |
| 2013 Q2 | 31.67 Million CNY | -5.86% |
| 2013 Q4 | 54.04 Million CNY | 59.92% |
| 2012 Q3 | -75.83 Million CNY | 0.0% |
| 2012 FY | 133.26 Million CNY | 29.93% |
| 2012 Q4 | -77.63 Million CNY | -2.38% |
| 2011 FY | 102.56 Million CNY | 33.28% |
| 2010 Q4 | 24.69 Million CNY | 0.0% |
| 2010 FY | 76.95 Million CNY | 18.97% |
| 2009 FY | 64.68 Million CNY | 25.05% |
| 2008 FY | 51.72 Million CNY | 55.31% |
| 2007 FY | 33.3 Million CNY | 0.0% |